This Week in Psychedelics - 3.18.22

Cannabis

  • Israeli Town of Tira Founds First Medical Cannabis Cafe (High Times)

  • Kentucky House Passes Medical Marijuana Legalization Bill (Marijuana Moment)

  • Delaware House Shoots Down Recreational Legalization Bill (High Times)

  • New VA Veteran Suicide Program Won’t Allow Cannabis as Treatment (High Times)

  • Mike Tyson's cannabis brand is making ear-shaped weed gummies (NBC News)

  • Marijuana Legalization Hasn’t Led To More Youth Use, Report From Alcohol And Tobacco Industry-Backed Group Says (Marijuana Moment)

  • Oklahoma Thieves Impersonate Cops and Raid Several Pot Farms (High Times)

  • Alabama Bill Would Force Women Who Want Medical Marijuana To Show Negative Pregnancy Tests (Marijuana Moment)

  • Montana Supreme Court OKs Temporary Rules For Cannabis Expungement (High Times)

  • New Orleans City Council Urges End To Marijuana Testing For Government Employees (Marijuana Moment)

  • Georgia Lawmakers Consider Separate Medical Cannabis Production Bills (High Times)

  • Some Mississippi Cities Move To Ban Medical Marijuana Businesses (Marijuana Moment)

  • European Commission Sets Standards for Hemp Food (High Times)

  • Jones Soda Company Announces Cannabis-Infused Product Line (High Times)

LSD

  • Montreal researchers find that, like Prozac, LSD may be useful for anxiety treatment (CTV News)

  • Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety (BioSpace)

Magic Mushrooms

  • California Activists Drop 2022 Psilocybin Legalization Ballot Initiative After Falling Short Of Signature Requirement (Marijuana Moment)

  • Little evidence on how psilocybin therapy interacts with existing psychiatric treatments, review finds (OHSU News)

  • California Psychedelics Investors Are Closely Monitoring Oregon’s Psilocybin Market (Willamette Week)

  • Washington State Legislature Approves $200,000 In Psilocybin Research Funding In Budget (Marijuana Moment)

  • Novamind announces phase 2 trial examining psilocybin for MDD (Healio)

  • Psilocybin Is The Most Studied Psychedelic (Green Market Report)

MDMA

  • MDMA-assisted psychotherapy for PTSD could save the health care system millions of dollars, study suggests (PsyPost)

  • Dose-ranging study provides insight into MDMA’s effects on memory, addiction, and depression (PsyPost)

Ayahuasca

  • Federal judge dismisses ayahuasca church’s request for overturn of DEA decision (WFTV)

  • Study will investigate ayahuasca to overcome prolonged grief (Ruetir)

  • Controversy Over Injustice Against Ayahuasca Traditional Knowledge Rebounds (Chacruna)

Ketamine

  • A Ketamine Clinic Treads the Line Between Health Care and a ‘Spa Day for Your Brain’ (The New York Times)

Miscellaneous

  • Connecticut Lawmakers Approve Bill To Fund Psilocybin And MDMA Therapy (Marijuana Moment)

  • Students Launch Bid to Decriminalize All Drugs in Ann Arbor, Michigan (Filter)

  • New Research Explores Whether Therapeutic Psychedelics Can Fix ‘Biophobia’ (Forbes)

  • Keywords from hallucinogenic experiences can help find parts of the brain affected by drugs (The Verge)

  • Feds Reveal Which Industries Drug Test Workers The Most And Least In New Report (Marijuana Moment)

  • MDMA use drops due to COVID lockdowns, other drugs rise -EU report (Reuters)

  • What do psychedelic drugs do to our brains? AI could help us find out (MIT Technology Review)

  • How Can We Apply Harm Reduction to HPPD? (Psychedelics Today)

  • Colorado Activists Pick One Of Several Psychedelics Reform Initiatives To Pursue For November Ballot (Marijuana Moment)

  • London should pilot drug checking and consumption rooms, says report (London Evening Standard)

  • Current Psychedelic Therapies Use Flawed Models of the Mind – It’s Time for Relational Therapy (Healing Maps)

  • Mind Cure Health Halts All Psychedelic Business Activity (Psychedelic Spotlight)

  • Are drug wars protection rackets? (Drug WarRant)

  • Microdosing Is On The Rise But Is It Healthy? (The Dales Report)

  • Terence McKenna’s Anarchic Psychedelic Religion (JSTOR Daily)

  • Coming of Age in the Psychedelic Sixties (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.